Advanced Enzyme Technologies Limited
NSE: ADVENZYMES BSE: ADVENZYMES
NSE
309.95
4.20 (1.37%)
Prev Close
305.75
Open Price
307.95
Volume
109,176
Today Low / High
305.55 / 312.25
52 WK Low / High
257.9 / 388.8
Range
294 - 325
BSE
310.20
4.95 (1.62%)
Prev Close
305.25
Open Price
305.3
Volume
2,950
Today Low / High
305.3 / 312.55
52 WK Low / High
257.85 / 391.85
Range
295 - 326
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 309.95 (target range: 294 - 325), reflecting a change of 4.2 (1.37367%). On the BSE, it is listed at 310.2 (target range: 295 - 326), showing a change of 4.95 (1.62162%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.
12 Dec
307.95
0.65%
11 Dec
304.95
0.26%
10 Dec
308.95
-1.57%
09 Dec
304.00
1.25%
08 Dec
306.95
-0.94%
05 Dec
311.20
-1.70%
04 Dec
313.15
0.27%
03 Dec
309.40
1.36%
02 Dec
312.55
-0.91%
01 Dec
311.00
0.45%
28 Nov
310.75
0.31%
27 Nov
315.15
-1.02%
26 Nov
312.15
0.90%
25 Nov
314.70
-0.71%
24 Nov
318.00
-1.89%
21 Nov
324.80
-2.34%
19 Nov
330.40
-0.68%
18 Nov
338.25
-2.32%
17 Nov
330.05
2.44%
Advanced Enzyme Technologies Limited Graph
Advanced Enzyme Technologies Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Advanced Enzyme Technologies Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 309.95, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 310.20 | 313.30 | 281.97 - 344.63 |
| 316.40 | 253.12 - 379.68 | ||
| 319.51 | 223.65 - 415.36 | ||
| Bearish Scenario | 310.20 | 307.10 | 276.39 - 337.81 |
| 304.00 | 243.20 - 364.80 | ||
| 300.89 | 210.63 - 391.16 |
Overview of Advanced Enzyme Technologies Limited
ISIN
INE837H01020
Industry
Chemicals - Specialty
Vol.Avg
242,253
Market Cap
34,680,413,053
Last Dividend
5.2
Official Website
IPO Date
2016-08-01
DCF Diff
-610.62
DCF
916
Financial Ratios Every Investor Needs
Stock Dividend of ADVENZYMES
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2025-07-23 | July 23, 25 | 1.2 | 1.2 | 2025-07-23 | 2025-08-05 | |
| 2025-05-16 | May 16, 25 | 4 | 4 | 2025-05-17 | 2025-06-10 | |
| 2024-07-18 | July 18, 24 | 1.1 | 1.1 | 2024-07-18 | 2024-08-24 | |
| 2024-05-17 | May 17, 24 | 4 | 4 | 2024-05-18 | 2024-06-05 | |
| 2023-08-04 | August 04, 23 | 1 | 1 | 2023-08-05 | 2023-09-11 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 636.91 Cr | 329.96 Cr | 306.95 Cr | 0.4819 | 0.88 Cr | 20.89 Cr | 157.88 Cr | 131.12 Cr | 11.70 | 227.48 Cr | 0.2059 |
| 2024-03-31 | 623.48 Cr | 159.41 Cr | 464.07 Cr | 0.7443 | 21.67 Cr | 24.07 Cr | 172.83 Cr | 133.31 Cr | 11.92 | 227.18 Cr | 0.2138 |
| 2023-03-31 | 540.64 Cr | 131.80 Cr | 397.61 Cr | 0.7355 | 21.66 Cr | 21.83 Cr | 129.69 Cr | 105.64 Cr | 9.45 | 178.90 Cr | 0.1954 |
| 2022-03-31 | 528.90 Cr | 119.43 Cr | 409.47 Cr | 0.7742 | 19.37 Cr | 20.72 Cr | 171.01 Cr | 119.58 Cr | 10.70 | 209.00 Cr | 0.2261 |
| 2021-03-31 | 500.45 Cr | 105.59 Cr | 394.85 Cr | 0.7890 | 15.51 Cr | 15.83 Cr | 290.85 Cr | 145.93 Cr | 13.07 | 241.42 Cr | 0.2916 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 107.69 Cr | 1,621.35 Cr | 152.68 Cr | 1,420.8630 Cr | 39.35 Cr | -68.34 Cr | 157.31 Cr | 314.63 Cr | 0.00 Cr | 0.00 Cr | 10.05 Cr | 96.7550 Cr |
| 2024-03-31 | 113.75 Cr | 1,535.46 Cr | 164.38 Cr | 1,324.1280 Cr | 47.31 Cr | -66.44 Cr | 148.46 Cr | 307.27 Cr | 8.93 Cr | 0.00 Cr | -26.98 Cr | 106.3570 Cr |
| 2023-03-31 | 96.42 Cr | 1,421.85 Cr | 137.68 Cr | 1,235.0690 Cr | 33.50 Cr | -62.92 Cr | 123.99 Cr | 288.82 Cr | 31.70 Cr | 7.78 Cr | 0.17 Cr | 77.5660 Cr |
| 2022-03-31 | 267.36 Cr | 1,267.61 Cr | 127.22 Cr | 1,088.5930 Cr | 34.73 Cr | -232.63 Cr | 120.92 Cr | 271.88 Cr | 24.50 Cr | 8.42 Cr | 0.07 Cr | 60.4220 Cr |
| 2021-03-31 | 191.92 Cr | 1,152.67 Cr | 121.90 Cr | 970.6560 Cr | 27.96 Cr | -164.30 Cr | 93.88 Cr | 243.24 Cr | 9.47 Cr | 1.36 Cr | 0.07 Cr | 67.5580 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 149.0980 Cr | -99.0440 Cr | -69.2020 Cr | 115.2900 Cr | -19.5240 Cr | 94.2250 Cr | -34.7810 Cr | 131.1150 Cr | -3.5780 Cr | -59.0300 Cr | -7.7970 Cr |
| 2024-03-31 | 141.3690 Cr | -64.6490 Cr | -59.2380 Cr | 99.0560 Cr | 17.3310 Cr | 113.7510 Cr | -42.3130 Cr | 133.3050 Cr | 12.0550 Cr | -56.7120 Cr | -23.8340 Cr |
| 2023-03-31 | 140.3620 Cr | -298.1810 Cr | -25.7980 Cr | 102.1810 Cr | -170.9350 Cr | 96.4200 Cr | -38.1810 Cr | 140.3880 Cr | 2.3000 Cr | -12.5420 Cr | 0.7550 Cr |
| 2022-03-31 | 122.2910 Cr | -24.9120 Cr | -27.3750 Cr | 94.1150 Cr | 75.4360 Cr | 267.3550 Cr | -28.1760 Cr | 171.0580 Cr | -8.1380 Cr | -11.8600 Cr | -26.0950 Cr |
| 2021-03-31 | 162.8920 Cr | -26.0330 Cr | -26.3100 Cr | 143.3120 Cr | 109.2550 Cr | 191.9190 Cr | -19.5800 Cr | 210.3710 Cr | -11.6860 Cr | -7.9810 Cr | -8.1800 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 184.53 Cr | 44.57 Cr | 139.96 Cr | 0.7585 | 49.98 Cr | 43.33 Cr | 3.87 | 70.34 Cr | 0.2348 |
| 2025-06-30 | 185.91 Cr | 50.05 Cr | 135.87 Cr | 0.7308 | 46.81 Cr | 39.93 Cr | 3.57 | 65.28 Cr | 0.2148 |
| 2025-03-31 | 167.18 Cr | 93.00 Cr | 74.18 Cr | 0.4437 | 35.53 Cr | 26.48 Cr | 2.36 | 54.35 Cr | 0.1584 |
| 2024-12-31 | 169.11 Cr | 38.83 Cr | 130.28 Cr | 0.7704 | 46.28 Cr | 37.65 Cr | 3.36 | 62.94 Cr | 0.2226 |
| 2024-09-30 | 146.10 Cr | 32.70 Cr | 113.40 Cr | 0.7762 | 33.52 Cr | 32.83 Cr | 2.94 | 52.03 Cr | 0.2247 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 62.36 Cr | 556.65 Cr | 619.01 Cr | 125.56 Cr | 173.42 Cr | 933.46 Cr | 315.47 Cr | 1,691.90 Cr | 158.33 Cr |
| 2025-06-30 | 0.00 Cr | 0.00 Cr | 592.28 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -1,468.67 Cr |
| 2025-03-31 | 107.69 Cr | 480.26 Cr | 587.94 Cr | 116.21 Cr | 157.31 Cr | 879.87 Cr | 314.63 Cr | 1,621.35 Cr | 152.68 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 506.99 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -1,388.79 Cr |
| 2024-09-30 | 111.27 Cr | 395.72 Cr | 506.99 Cr | 98.88 Cr | 168.41 Cr | 805.39 Cr | 315.03 Cr | 1,549.18 Cr | 160.40 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 39.93 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2025-03-31 | 26.48 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 37.65 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 32.83 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 34.15 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2017-05-25 | May 25, 17 | 5:1 |
Similar Stocks: Chemicals - Specialty
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Asian Paints Limited | ASIANPAINT | ₹2,764.80 | ₹2,650,431,916,339.00 | ₹977,559.00 |
| Pidilite Industries Limited | PIDILITIND | ₹1,476.80 | ₹1,502,960,082,458.00 | ₹331,353.00 |
| Solar Industries India Limited | SOLARINDS | ₹12,295.00 | ₹1,112,575,226,225.00 | ₹81,175.00 |
| SRF Limited | SRF | ₹3,020.00 | ₹895,202,971,500.00 | ₹813,951.00 |
| Berger Paints India Limited | BERGEPAINT | ₹541.00 | ₹630,749,075,439.00 | ₹168,571.00 |
| Linde India Limited | LINDEINDIA | ₹6,006.00 | ₹512,217,043,338.00 | ₹23,636.00 |
| Himadri Speciality Chemical Limited | HSCL | ₹466.00 | ₹230,051,135,690.00 | ₹864,038.00 |
| DCM Shriram Limited | DCMSHRIRAM | ₹1,241.10 | ₹193,942,799,946.00 | ₹254,434.00 |
| Kansai Nerolac Paints Limited | KANSAINER | ₹223.70 | ₹180,866,139,647.00 | ₹155,858.00 |
| Atul Ltd | ATUL | ₹5,928.00 | ₹174,530,723,640.00 | ₹18,347.00 |
| BASF India Limited | BASF | ₹3,903.00 | ₹168,943,852,920.00 | ₹25,744.00 |
| Vinati Organics Limited | VINATIORGA | ₹1,592.60 | ₹165,097,885,523.00 | ₹13,569.00 |
| Akzo Nobel India Limited | AKZOINDIA | ₹3,601.20 | ₹163,999,778,777.00 | ₹55,014.00 |
| Anupam Rasayan India Limited | ANURAS | ₹1,319.50 | ₹145,919,985,894.00 | ₹476,239.00 |
| Acutaas Chemicals Ltd. | ACUTAAS | ₹1,662.50 | ₹136,107,082,825.00 | ₹146,001.00 |
| Fine Organic Industries Limited | FINEORG | ₹4,409.20 | ₹135,185,966,179.00 | ₹18,342.00 |
| Aarti Industries Limited | AARTIIND | ₹355.00 | ₹128,720,823,495.00 | ₹374,303.00 |
| Privi Speciality Chemicals Limited | PRIVISCL | ₹3,076.10 | ₹120,160,789,927.00 | ₹32,613.00 |
| PCBL Limited | PCBL | ₹313.30 | ₹118,241,021,276.00 | ₹272,270.00 |
| Aether Industries Limited | AETHER | ₹864.80 | ₹114,664,040,417.00 | ₹127,220.00 |
| Ami Organics Limited | AMIORG | ₹1,176.30 | ₹96,302,382,365.00 | ₹242,994.00 |
| Clean Science and Technology Limited | CLEAN | ₹905.00 | ₹96,177,970,000.00 | ₹194,965.00 |
| Garware Hi-Tech Films Limited | GRWRHITECH | ₹3,688.50 | ₹85,692,685,269.00 | ₹52,196.00 |
| Alkyl Amines Chemicals Limited | ALKYLAMINE | ₹1,596.20 | ₹81,636,016,087.00 | ₹21,649.00 |
| Sudarshan Chemical Industries Limited | SUDARSCHEM | ₹996.50 | ₹78,331,350,345.00 | ₹171,070.00 |
| Galaxy Surfactants Limited | GALAXYSURF | ₹1,987.40 | ₹70,462,774,125.00 | ₹8,397.00 |
| Indigo Paints Limited | INDIGOPNTS | ₹1,233.90 | ₹58,786,304,086.00 | ₹25,446.00 |
| Gulf Oil Lubricants India Limited | GULFOILLUB | ₹1,159.20 | ₹57,135,028,658.00 | ₹35,375.00 |
| Responsive Industries Limited | RESPONIND | ₹194.57 | ₹51,874,024,406.00 | ₹36,993.00 |
| Kingfa Science & Technology (India) Limited | KINGFA | ₹3,853.30 | ₹49,443,476,378.00 | ₹1,953.00 |
| Laxmi Organic Industries Limited | LXCHEM | ₹170.90 | ₹47,364,571,496.00 | ₹193,935.00 |
| Pondy Oxides And Chemicals Limited | POCL | ₹1,303.90 | ₹36,947,679,404.00 | ₹102,183.00 |
| Balaji Amines Limited | BALAMINES | ₹1,119.80 | ₹36,282,639,800.00 | ₹29,920.00 |
| Jubilant Agri and Consumer Products Ltd. | JUBLCPL | ₹2,339.10 | ₹35,435,713,595.00 | ₹2,080.00 |
| Advanced Enzyme Technologies Limited | ADVENZYMES | ₹309.95 | ₹34,680,413,053.00 | ₹109,176.00 |
| Tatva Chintan Pharma Chem Limited | TATVA | ₹1,437.60 | ₹33,628,418,268.00 | ₹66,675.00 |
| Vishnu Chemicals Limited | VISHNU | ₹496.65 | ₹33,432,135,799.00 | ₹52,281.00 |
| Rossari Biotech Limited | ROSSARI | ₹585.35 | ₹32,410,975,252.00 | ₹12,997.00 |
| Kiri Industries Limited | KIRIINDUS | ₹565.00 | ₹31,430,374,830.00 | ₹281,741.00 |
| Camlin Fine Sciences Limited | CAMLINFINE | ₹162.60 | ₹30,565,548,000.00 | ₹5,091,890.00 |
| Ddev Plastiks Industries Ltd. | DDEVPLSTIK | ₹283.70 | ₹29,356,329,577.00 | ₹55,242.00 |
| Grauer & Weil (India) Limited | GRAUWEIL | ₹117.90 | ₹29,075,437,490.00 | ₹464,402.00 |
| Neogen Chemicals Limited | NEOGEN | ₹1,089.70 | ₹28,748,110,158.00 | ₹1,697,436.00 |
Key Executives
Senior Vice President of Marketing & Business Development
Mr. Dipak Roda
Gender: male
Year Born: 1973
Investor Relations Manager
Mr. Ronak Saraf
Gender: male
Year Born:
MD & Head of Business Development - evoxx technologies GmbH
Ms. Martina Doering
Gender: female
Year Born:
Chief Financial Officer & Chief Operating Officer of US Subsidiaries
Mr. Harshad Doshi
Gender: male
Year Born:
Company Secretary, Head of Legal & Compliance Officer
Mr. Sanjay Prakash Basantani
Gender: male
Year Born:
MD & Head of Research and Development - evoxx technologies GmbH
Dr. Michael Puls
Gender: Not Specified
Year Born:
Plant Manager & Head of Operations - Sinnar
Mr. Satish B Pagar
Gender: male
Year Born:
Chief Financial Officer
Mr. Beni Prasad Rauka CA
Gender: male
Year Born: 1964
General Manager of Human Resources & Administration
Mr. Bhaskar Manolkar
Gender: male
Year Born: 1959
FAQs about Advanced Enzyme Technologies Limited
Who is the CEO of the company?
The CEO is Beni Prasad Rauka.
What is the current market price of the stock?
The current price is ₹309.95.
What is the 52-week price range?
The range is ₹257.9-388.8.
What is the market capitalization of the company?
The market capitalization is ₹3,468.04 crores.
What is the dividend yield?
The dividend yield is 1.68%.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is 23.54.
Which sector does the company belong to?
The company operates in the Basic Materials sector.
What does the company do?
Overview of Advanced Enzyme Technologies Limited (ISIN: INE837H01020) is a leading Chemicals - Specialty in India. With a market capitalization of ₹3,468.04 crores and an average daily volume of 242,253 shares, it operates in the Chemicals - Specialty. The company last declared a dividend of ₹5.2.